Treatment of ARDS With Instilled T3

PHASE2RecruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
ARDS, HumanLung, WetThyroidPulmonary EdemaLung Inflammation
Interventions
DRUG

Liothyronine Sodium (T3+0.9% sodium chloride) modified formulation specifically for airway instillation.

"Study Drug Administration:~* Dose/Volume- Liothyronine Sodium 50 mcg / 10 mL~* Frequency/Duration: Twice daily over 5 days (10 total doses), or until extubation, whichever comes first.~* Method: Instilled via a catheter through the ETT directly into the airway."

OTHER

Non-intervention

Standard of Care (SOC)

Trial Locations (2)

55435

RECRUITING

M Health Fairview Southdale Hospital, Edina

55455

RECRUITING

East Bank Hospital - M Health Fairview University of Minnesota Medical Center, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER